SCHEMBL5282613

SCHEMBL5282613

CC(=O)Oc1cc(Br)c(O)c(Br)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 2/20 0.42
AKR1B1 P15121 2/20 0.42
POLB P06746 1/20 0.41
GPR35 Q9HC97 2/20 0.40
KDM4E B2RXH2 3/20 0.38
LMNA P02545 1/20 0.37
TSHR P16473 3/20 0.37
ALDH1A1 P00352 2/20 0.37
HSD17B10 Q99714 2/20 0.37
LCK P06239 1/20 0.37
FYN P06241 1/20 0.37
TNFSF11 O14788 1/20 0.37
ESR1 P03372 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
HMGB1 P09429 1/20 0.37
HPGD P15428 1/20 0.37
GGT1 P19440 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283377 0.82 THRA (0.37) CFDAKR1B1POLBKDM4ELCK
SCHEMBL7122561 0.81 ACHE (0.41) AKR1B1GPR35KDM4ELMNATSHR
SCHEMBL14597441 0.76 CFD (0.48) CFDKDM4ETSHRALDH1A1HSD17B10
SCHEMBL5277949 0.75 THRA (0.43) CFDPOLBKDM4ELMNAHTT
SCHEMBL9477803 0.74 CFD (0.44) CFDKDM4ELMNATSHRALDH1A1
SCHEMBL2912166 0.72 POLB (0.56) CFDPOLBKDM4ETSHRALDH1A1
SCHEMBL18281055 0.72 AKR1C4 (0.52) GPR35KDM4ELMNAALDH1A1HSD17B10
SCHEMBL5282022 0.71 BACE1 (0.48) CFDPOLBKDM4ELMNAALDH1A1
SCHEMBL7114628 0.71 CYP3A4 (0.47) POLBKDM4ELMNATSHRALDH1A1
SCHEMBL8898882 0.70 CFD (0.58) CFDKDM4ELMNATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1862450-A2 Novel compounds KARO BIO AB (SE) 2007-12-05 EP disclosed
EP-1537073-B1 BENZAMIDE OR PHENYLACETAMIDE DERIVATIVES USEFUL AS THYROID RECEPTOR LIGANDS KAROBIO AB (SE) 2007-09-12 EP disclosed
US-20060135614-A1 Novel compounds NORIN, THOMAS ANDERS WILSON (SE) 2006-06-22 US disclosed
EP-1537073-A2 BENZAMIDE OR PHENYLACETAMIDE DERIVATIVES USEFUL AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2005-06-08 EP disclosed
WO-2004007430-A2 BENZAMIDE OR PHENYLACETAMIDE DERIVATIVES USEFUL AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135614-A1 Novel compounds THRB, TSHR, THRA CFD 4772/4885AKR1B1 628/4885POLB 3600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.